Regeneron Pharmaceuticals
REGN
#376
Rank
C$94.15 B
Marketcap
C$898.13
Share price
2.06%
Change (1 day)
25.23%
Change (1 year)

Earnings for Regeneron Pharmaceuticals (REGN)

Earnings in 2026 (TTM): C$7.10 Billion

According to Regeneron Pharmaceuticals's latest financial reports the company's current earnings are C$14.91 Billion. In 2025 the company made an earning of C$7.42 Billion, an increase over its 2024 earnings that were of C$6.78 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Regeneron Pharmaceuticals from 1990 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) C$7.10 B-4.26%
2025 C$7.42 B9.43%
2024 C$6.78 B13.83%
2023 C$5.95 B-13.57%
2022 C$6.89 B-47.9%
2021 C$13.23 B144.75%
2020 C$5.40 B56.86%
2019 C$3.44 B-4.87%
2018 C$3.62 B22.86%
2017 C$2.94 B56.3%
2016 C$1.88 B8.55%
2015 C$1.73 B54.53%
2014 C$1.12 B11.14%
2013 C$1.01 B72.13%
2012 C$0.58 B-285.93%
2011 -C$0.32 Billion121.73%
2010 -C$0.15 Billion37.18%
2009 -C$0.11 Billion-14.6%
2008 -C$0.13 Billion-25.02%
2007 -C$0.17 Billion6.32%
2006 -C$0.16 Billion-186.52%
2005 C$0.17 B2103.7%
2004 C$8.01 M-105.66%
2003 -C$0.15 Billion-18.18%
2002 -C$0.18 Billion42.33%
2001 -C$0.13 Billion129.35%
2000 -C$53.02 Million51.87%
1999 -C$34.91 Million92.19%
1998 -C$18.17 Million66.23%
1997 -C$10.93 Million-55.49%
1996 -C$24.55 Million103.53%
1995 -C$12.07 Million-70.89%
1994 -C$41.44 Million-26.08%
1993 -C$56.06 Million114.67%
1992 -C$26.12 Million196.77%
1991 -C$8.8 Million87.88%
1990 -C$4.69 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
C$36.86 B 403.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$22.39 B 206.08%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Amgen
AMGN
C$12.89 B 76.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
C$10.86 B 48.51%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
C$2.30 B-68.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
C$1.23 B-83.14%๐Ÿ‡บ๐Ÿ‡ธ USA